Connor, Clark & Lunn Investment Management (CC&L)’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-15,200
Closed -$1.22M 1076
2016
Q4
$1.22M Sell
15,200
-200
-1% -$15.9K 0.01% 449
2016
Q3
$1.23M Buy
15,400
+9,500
+161% +$767K 0.01% 442
2016
Q2
$460K Buy
5,900
+100
+2% +$7.13K ﹤0.01% 596
2016
Q1
$319K Buy
+5,800
New +$316K ﹤0.01% 638
2015
Q1
Sell
-16,252
Closed -$1.06M 647
2014
Q4
$1.06M Sell
16,252
-19,000
-54% -$1.22M 0.01% 299
2014
Q3
$2.12M Sell
35,252
-5,200
-13% -$340K 0.02% 211
2014
Q2
$2.98M Buy
40,452
+100
+0.2% +$6.48K 0.02% 202
2014
Q1
$2.91M Buy
40,352
+33,100
+456% +$2.15M 0.02% 230
2013
Q4
$477K Buy
+7,252
New +$420K ﹤0.01% 502

Other funds holding STJ

Connor, Clark & Lunn Investment Management (CC&L)'s STJ Position: Q1 2017 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 15,200 shares — an estimated $1.22M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in STJ in Q4 2013 and held it in 9 quarters. The position peaked at $2.98M in Q2 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 15,200 St Jude Medical shares in Q1 2017, an estimated $1.22M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in St Jude Medical in Q4 2013 and held it in 9 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s St Jude Medical position peaked at $2.98M in Q2 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2017, filed 15 May 2017.